Effectiveness and safety of eltrombopag in connective tissue disease patients with refractory immune thrombocytopenia: a retrospective study

CONCLUSIONS: Eltrombopag appears to be effective, safe and well-tolerated in refractory ITP patients with CTD; larger studies are needed to confirm the generalizability of these findings.PMID:38495431 | PMC:PMC10942842 | DOI:10.1093/rap/rkae029

Source: Adv Data - March 18, 2024 Category: Epidemiology Authors: Xiangpin Jiang Xiaoming Shu Yongpeng Ge Source Type: research